Basic Information
ID: ALA4006202
Type: ADME
Description: Drug metabolism in CD1 mouse liver assessed as oxidative metabolites formation at 6 mg/kg, ip dosed once daily for 3 days followed by dosing of 1:1 mixtures of 2-(2-(Carboxy-13C)ethyl)-4-methyl-5-propylfuran-3-carboxylic-2-13C Acid and test compound on day 4 and 5 measured 1 hr post dose on day 5 by HPLC-MS analysis
Format: BAO_0000218
Organism: Mus musculus
Strain: CD1
Tissue: Liver
Target: Liver(ALA613580)
Document: ALA4004837
Drug metabolism in CD1 mouse liver assessed as oxidative metabolites formation at 6 mg/kg, ip dosed once daily for 3 days followed by dosing of 1:1 mixtures of 2-(2-(Carboxy-13C)ethyl)-4-methyl-5-propylfuran-3-carboxylic-2-13C Acid and test compound on day 4 and 5 measured 1 hr post dose on day 5 by HPLC-MS analysis: 1
Activity Charts
Bioactivity
Activity Types for Assay ALA4006202
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 240.25 | 2.26 | 2.26 |